FIELD: medicine.
SUBSTANCE: invention relates to biochemistry. Described is method of inducing apoptosis of malignant tumour cells of colorectal cancer. Inhibition of function of genes from group: c-IAP2, Livin and MCM4 is carried out. For this purpose applied are medications of small interfering miRNA-oligonucleotides from group UGUGGACAAAGUCUCUUCCdTdT; CCUGUGGGUAAGAAGAUGAGdTdT; UUCUCUCUCCUCUUCCCUUAdTdT. Simultaneous inhibition of functions of genes from group: c-IAP2, Livin and MCM4, in one of gene combination: Livin and MCM4; c-IAP2 and MCM4; c-IAP2 and Livin is performed. In particular, simultaneous inhibition of functions of two genes from group: c-IAP2, Livin and MCM4 is carried out. Disclosed is means for said method realisatio, which contains oxaliplatin and combination of complementary to mRNA in cells of malignant tumour shRNA-oligonucleotides in form of short loop shRNA.
EFFECT: invention makes it possible to optimise and activate apoptotic influences of platinum-containing medication on cells of colorectal cancer tumour, which ensures essential apoptotic death of cancer cells with dose of medication, fundamentally lower than the standard one.
7 cl, 3 dwg, 1 tbl
| Title | Year | Author | Number |
|---|---|---|---|
| COMPOSITION FOR INHIBITING GROWTH AND STIMULATION OF APOPTOSIS OF COLORECTAL CANCER CELLS | 2016 |
|
RU2644675C1 |
| SIRNA-BASED COMPOSITION FOR INHIBITING Gal-9 (LGALS9), PREPARATION BASED THEREON AND METHOD OF USING IT AS TARGETED IMMUNOSTIMULANT IN ANTI-PD-L1 THERAPY | 2023 |
|
RU2832798C1 |
| ONCOLYTIC VIRAL VECTORS AND USE THEREOF | 2017 |
|
RU2749050C2 |
| METHODS OF TREATING CANCER, HAVING HEMIZYGOUS LOSS OF TP53 | 2016 |
|
RU2721953C2 |
| ANALYSES AND METHODS OF BIOMARKER APPLICATION | 2006 |
|
RU2409817C2 |
| TREATMENT OF DISEASES, ASSOCIATED WITH PROTEIN OF PROSTATE APOPTOTIC RESPONSE PAR4, BY INHIBITION OF NATURAL ANTISENSE TRANSCRIPT OF PAR4 GENE | 2011 |
|
RU2575608C2 |
| OLIGONUCLEOTIDES FOR MODULATING GENE EXPRESSION AND USES THEREOF | 2013 |
|
RU2648140C2 |
| COMPOSITION AND METHOD OF TUMOUR CURING | 2007 |
|
RU2500815C2 |
| AGENT INDUCING CELL DEATH, CELL GROWTH INHIBITING AGENT, AND PHARMACEUTICAL COMPOSITION FOR TREATING DISEASE CAUSED BY ABNORMAL CELL GROWTH | 2015 |
|
RU2707746C2 |
| COMPOSITION FOR PREVENTION OR TREATMENT OF DISEASE ASSOCIATED WITH OBESITY, CONTAINING AMPHIREGULIN-SPECIFIC DOUBLE-CHAIN OLIGONUCLEOTIDE STRUCTURE | 2021 |
|
RU2810514C1 |
